Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare but life-threatening heart disease caused by the buildup of abnormal deposits of transthyretin protein in the heart. For years, patients suffering from this condition had very few treatment options available. However, due to significant medical advancements in recent times, ATTR-CM patients now have real hope for managing their disease and improving outcomes. In this article, we examine the latest treatment approaches and ongoing ... Read more
